Isolated limb infusion with melphalan and actinomycin D in melanoma patients: Factors predictive of acute regional toxicity

Expert Opinion on Drug Metabolism and Toxicology

Volumn 6, Issue 9, 2010, Pages 1039-1045

  Kam, Peter Ca ^a   Thompson, John F ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Isolated limb infusion; Melanoma; Regional chemotherapy; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE; CREATININE; CYTOTOXIC AGENT; DACTINOMYCIN; FOTEMUSTINE; HEPARIN; MELPHALAN; PAPAVERINE; TROPISETRON;

ADD ON THERAPY; AREA UNDER THE CURVE; BODY WEIGHT; CREATINE KINASE BLOOD LEVEL; DISEASE CONTROL; DRUG EFFICACY; GENDER; HUMAN; HYPERTHERMIA; ISOLATED LIMB INFUSION; LIMB DISEASE; LIMB PERFUSION; MELANOMA; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; PREDICTION; PROSPECTIVE STUDY; REVIEW; TREATMENT RESPONSE; TUMOR REGRESSION; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DACTINOMYCIN; EXTREMITIES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, INTRA-ARTERIAL; MALE; MELANOMA; MELPHALAN; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 77955832676     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.2010.503703     Document Type: Review

References (30)

1. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179-185
2. Lingam MK, Byrne DS, Aitchison T, et al. A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb. Eur J Cancer 1996;32A:1668-1673
3. McKay A, Byrne DS. Recurrent limb melanoma: treatments other than isolated limb perfusion and infusion. In: Thompson JF, Morton DL, Kroon BB, editors, Textbook of melanoma. Martin Dunitz, London; 2004. p. 443-448
4. Rossi CR, Foletto M, Vecchiato A, et al. Management of cutaneous melanoma: state of the art and trends. Eur J Cancer 1997;33:2302-2312
5. Creech O Jr, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958;148:616-632
6. Thompson JF, de Wilt JH. Isolated limb perfusion in the management of patients with recurrent limb melanoma: an important but limited role. Ann Surg Oncol 2001;8:564-565
7. Karakousis CP, Kanter PM, Lopez R, et al. Modes of regional chemotherapy. J Surg Res 1979;26:134-41
8. Bland KI, Kimura AK, Brenner DE, et al. A phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and intransit malignant melanoma of the extremities using tourniquet outflow-occlusion techniques. Ann Surg 1989;209:73-80
9. Karakousis CP, Kanter PM, Park HC, et al. Tourniquet infusion versus hyperthermic perfusion. Cancer 1982;49:850-858
10. Thompson JF, Waugh RC, Saw RPM, Kam PC. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion. Reg Cancer Treat 1994;7:188-192
11. Brady MS, Brown K, Patel A, et al. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity. Ann Surg Oncol 2006;13:1123-1129
12. Mian R, Henderson MA, Speakman D, et al. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion. Can J Surg 2001;44:189-192
13. Thompson JF, Kam PC, Waugh RC, Harman CR. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol 1998;14:238-247
14. Wieberdink J, Benckhuysen C, Braat RP, et al. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 1982;18:905-910
15. Thompson JF, Kam PCA, de Wilt JHW, Lindner P. Isolated limb infusion for melanoma. In: Thompson JF, Morton DL, Kroon BB, editors, Textbook of melanoma. Martin Dunitz, London; 2004. p. 429-437
16. Thompson JF, Kam PCA. Current status of isolated limb infusion with mild hyperthermia for melanoma. Int J Hyperthermia 2008;24:219-225
17. Thompson JF, Ramzan I, Kam PCA, Yau DF. Pharmacokinetics of melphalan during isolated limb infusion for melanoma. Reg Cancer Treat 1996;9:13-16 (Pubitemid 26360195)
18. Kam PCA, Thompson JF. Pharmacokinetics of regional therapy: low flow and other techniques for extremity melanoma. Surg Oncol Clin N Am 2008;17:795-804
19. Lindner P, Doubrovsky A, Kam PCA, et al. Prognostic factors after isolated limb infusion for melanoma. Ann Surg Oncol 2002;9:127-136
20. Kroon HM, Moncrieff M, Kam PCA, et al. Outcomes following isolated limb infusion for melanoma. A 14 year experience. Ann Surg Oncol 2008;15:3003-3013
21. Kroon HD, Moncrieff M, Kam PCA, Thompson JF. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Ann Surg Oncol 2009;16:1184-1192
22. Beasley GM, Caudie A, Peterson RP, et al. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg 2009;208:706-715
23. Beasley GM, Peterson RP, Yoo J, et al. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol 2008;15:2195-2205
24. Santillan AA, Delman KA, Beasley GM, et al. Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis. Ann Surg Oncol 2009;16:2570-2578
25. Cavaliere R, Ciocatto EC, Giovanella BC, et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 1967;20:1351-1381
26. Siemann DW, Chapman M, Beikirch A. Effects of oxygenation and pH on tumour cell response to alkylating chemotherapy. Int J Radiat Oncol Biol Phys 1991;20:287-289
27. Skarsgard LD, Skwarchuk MW, Vinczan A, et al. The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake. Anticancer Res 1995;15:219-223
28. Bonenkamp JJ, Thompson JF, de Wilt JH, et al. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional. Eur J Surg Oncol 2004;30:1107-1112
29. Wu ZY, Smithers BM, Anderson C, et al. Can tissue drug concentrations be monitored by microdialysis during and after isolated limb perfusion for melanoma treatment? Melanoma Res 2000;10:47-54
30. Thompson JF, Siebert GA, Anissimov YG, et al. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. Br J Cancer 2001;85:157-165